FDA Inspection 1119128 — Geisinger Medical Center Blood Bank
The FDA completed an inspection of Geisinger Medical Center Blood Bank on January 14, 2020 in Danville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 14, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Danville, PA (United States)